CSI Market
Sign In | Register

Amag Pharmaceuticals inc (AMAG) Annual Balance Sheets

Annual · GAAP · USD millions
Access AMAG quarterly Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Amag Pharmaceuticals inc's financial structure and capital allocation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2019)
(Dec 31 2018) (Dec 31 2017) (Dec 31 2016) (Dec 31 2015)
Assets
Cash & cash equivalent113.01
Available-for-sale Securities, Debt Securities, Current MA58.74
Cash & Short-term Investments171.00
Accounts receivable94.16
Notes, Loans and Financing Receivable, Gross, Current NO0.00
Inventories31.55
Other Current Assets0.00
Prepaid Expense And Other Assets Current19.10
Total Current Assets316.57
Equipment/Property/Plant Net4.12
Goodwill net422.51
Intangible Assets23.62
Long-term investments0.00
Other Assets, Noncurrent24.41
Deferred Income Tax Assets Net0.63
Restricted Cash Noncurrent0.50
Total Assets791.23
Liabilities
Accounts Payable, Current AC27.02
Accrued Liabilities, Current AC183.38
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current4.08
Deferred Revenue, Current DE0.00
Business Combination, Contingent Consideration, Liability, Current BU0.02
Total Current Liabilities214.50
Long-term debt0.00
Convertible Debt, Noncurrent LO277.03
Total Long-term Debt277.03
Deferred Revenue, Noncurrent DE0.00
Deferred Tax Liabilities, Net, Noncurrent LI0.00
Other liabilities, Noncurrent19.88
Contract With Customer Liability Current0.00
Business Acquisition Fair Value Contingent Consideration Noncurrent0.00
Total Liabilities511.41
Stockholders' Equity
Common Stock Value0.34
Additional Paid In Capital Common Stock1,297.92
Retained Earnings / Accumulated Deficit-1,015.20
Other Equity-3.24
Common Stockholder's Equity279.82
Total Stockholder's Equity279.82
Liabilities & Stockholder's Equity791.23
4 historic quarters locked

Sign in to unlock the full Amag Pharmaceuticals inc balance sheet history.

Sign In Create Free Account

About AMAG Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.